These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 5803846)

  • 1. [Contributions to the study of the immunosuppressive action of chloramphenicol].
    Dimitriu CG; Grimberg L; Medrea O; Pompilian V; Pop S; Avram M
    Med Interna (Bucur); 1969 Apr; 21(4):431-41. PubMed ID: 5803846
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunosuppressive therapy of collagen diseases. Case report].
    Miti L; Massei V; Sanguinetti CM
    Minerva Med; 1974 Mar; 65(24):1310-4. PubMed ID: 4831470
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of immunosuppressive agents on renal and other changes in (NZBX NZW)F1 hybrid New Zealand mice].
    Abe C; Shiokawa Y; Tanaka K
    Ryumachi; 1974 Mar; 14(1):43-52. PubMed ID: 4155127
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lupus kidney and immunosuppressive agents].
    Huriet C
    Bull Soc Fr Dermatol Syphiligr; 1970; 77(3):407-10. PubMed ID: 5510736
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunosuppressive therapy].
    Miescher PA; Gerebtzoff A; Lambert PH
    Ergeb Inn Med Kinderheilkd; 1974; 34(0):1-22. PubMed ID: 4154072
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunosuppressive agents].
    Lagrue G; Bariéty J; Druet P
    Acquis Med Recent; 1970; ():43-61. PubMed ID: 5526182
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of autoimmune diseases with antimitotics].
    Salmon J; Lambert PH
    Arch Belg Dermatol Syphiligr; 1968; 24(3):297-309. PubMed ID: 5312106
    [No Abstract]   [Full Text] [Related]  

  • 8. Problems with immunosuppressive agents in renal disease.
    Cameron JS
    J Clin Pathol Suppl (R Coll Pathol); 1975; 9():24-35. PubMed ID: 783212
    [No Abstract]   [Full Text] [Related]  

  • 9. [Results of systemic lupus erythematosus treatment in 300 patients].
    Kardaszewicz E; Siejeńska L
    Pol Tyg Lek; 1981 May; 36(20):715-8. PubMed ID: 7279743
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunosuppressive therapy of primary chronic polyarthritis and systemic lupus erythematodes disseminatus].
    Ricken D; Marsteller HJ; Baack G
    Med Welt; 1971 Sep; 39():1501-6. PubMed ID: 5106870
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunosuppressive therapy of visceral lupus erythematosus].
    Apostoloff E; Reitzig P; Apostoloff G
    Dtsch Gesundheitsw; 1973 Mar; 28(9):390-3. PubMed ID: 4714017
    [No Abstract]   [Full Text] [Related]  

  • 12. Systemic lupus erythematosus in the younger patient: survival studies.
    Abeles M; Urman JD; Weinstein A; Lowenstein M; Rothfield NF
    J Rheumatol; 1980; 7(4):515-22. PubMed ID: 7420333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of prolonged treatment in disseminated lupus erythematosus (D.L.E.)].
    Nestor R; Medrea O; Pop S; Sozanschi M; Badea I; Dimitriu CG
    Med Interna (Bucur); 1967 Jul; 19(7):835-44. PubMed ID: 6052170
    [No Abstract]   [Full Text] [Related]  

  • 14. Bullous systemic lupus erythematosus induced by the therapy for lupus nephritis.
    Jedlickova H; Bohmová J; Sirotkova A
    Int J Dermatol; 2008 Dec; 47(12):1315-6. PubMed ID: 19126028
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunosuppressive drugs in systemic lupus erythematosus and rheumatoid arthritis].
    Talpaz M
    Harefuah; 1980; 98(10):468-71. PubMed ID: 7450579
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical Images:Lupus erythematosus cells in the kidney and synovial fluid.
    Atiquzzaman BM; Ricciardi DD; Yazici Y; Gibofsky A
    Arthritis Rheum; 2001 Jan; 44(1):169. PubMed ID: 11212155
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pregnancy and immunosuppressive agents].
    von Fischer B; Gigon U; Sidiropoulos D; Montandon A
    Gynakol Rundsch; 1981; 21(3):141-58. PubMed ID: 7019014
    [No Abstract]   [Full Text] [Related]  

  • 18. Trials with cyclophosphamide in systemic lupus erythematosus.
    Sato FF
    Am J Nurs; 1972 Jun; 72(6):1077-9. PubMed ID: 4481770
    [No Abstract]   [Full Text] [Related]  

  • 19. Primary ascites as the presenting feature of systemic lupus erythematosus: response to cyclosporin therapy.
    Hernández Pérez J; Fernández Fernández J; Sanz Moreno C; Garrancho JM; Botella J
    Nephrol Dial Transplant; 1995; 10(8):1451-3. PubMed ID: 8538943
    [No Abstract]   [Full Text] [Related]  

  • 20. Prolonged B-cell depletion following rituximab therapy in systemic lupus erythematosus: a report of two cases.
    Lu TY; Jónsdóttir T; van Vollenhoven RF; Isenberg DA
    Ann Rheum Dis; 2008 Oct; 67(10):1493-4. PubMed ID: 18791057
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.